Aggrenox®

MATCH

Study Objectives and Design

The MATCH trial was designed to determine:

  • The efficacy and safety of ASA compared to placebo in high-risk cerebrovascular patients receiving clopidogrel 75mg

References

Diener HC. WSC Vancouver. June 2004.

previous 1|2|3|4|5 next